Effectiveness of a Novel Workplace-based Exercise Intervention: a Pilot Study
1 other identifier
interventional
23
1 country
1
Brief Summary
Sufficient physical activity and a good cardiorespiratory fitness level (CRF) are central in cardiovascular disease (CVD) risk reduction. However, many people remain inactive, partly because current exercise recommendations fail to address important barriers to exercise. A novel exercise protocol has previously been developed called 'reduced-exertion high-intensity interval training' (REHIT), which can remove several common perceived barriers to exercise. REHIT 1) improves CRF and other key CVD risk factors, 2) is genuinely time-efficient (total time-commitment of just 2x10 min per week), 3) is well-tolerated, manageable, and not associated with negative affective responses, and 4) can be done in the workplace, in work-clothes and without a need to shower afterwards. To date, this intervention has only been investigated in a lab-setting. Therefore, in the present randomised controlled trial, the 'real-world' effectiveness of REHIT in improving maximal aerobic capacity (V̇O2max; a key risk factors of CVD) will be investigated in a workplace setting. Participants' attitudes and psychological responses to REHIT will be assessed to evaluate the likelihood of successful implementation. In 2 study centres, a total of up to n=50 physically inactive male and female office workers will be recruited to perform 6 weeks of unsupervised, computer-guided, office-based REHIT (n=25) or act as a control (n=25).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedFirst Posted
Study publicly available on registry
May 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 2019
CompletedMarch 24, 2020
March 1, 2020
5 months
April 26, 2019
March 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in maximal aerobic capacity
Aerobic capacity: a key risk factor of noncommunicable disease
Change from baseline to 3 days after the 6-week intervention
Secondary Outcomes (4)
Change in motivation for exercise
Change from baseline to 3 days after the 6-week intervention
Change in health status
Change from baseline to 3 days after the 6-week intervention
Change in perceived stress
Change from baseline to 3 days after the 6-week intervention
Intervention acceptability
3 days after the 6-week intervention
Study Arms (2)
Exercise
EXPERIMENTALParticipants allocated to the intervention group will be asked to perform 2 exercise sessions per week for 6 weeks. Each session will involve 10 min of low-intensity cycling (25 W) interspersed with two 20-s 'all-out' cycle sprints against a resistance equivalent to 5% of body mass. The exercise intervention will be delivered on a commercially available cycle ergometer with software developed by CAR.O.L.
Control
NO INTERVENTIONThe effects of the intervention will be compared to a no-intervention control group recruited from the same workplace settings.
Interventions
REHIT is a type of Sprint Interval Training (SIT) that has been shown to be efficacious at improving maximal aerobic capacity using a minimal volume of exercise.
Eligibility Criteria
You may qualify if:
- Employee at participating workplace
You may not qualify if:
- Aged \< 18 years or \> 60 years
- History of type 2 diabetes
- Insulin therapy
- Use of β-blockers
- Use of inhaled steroids (e.g. for asthma)
- Any cardiovascular condition with the exception of well-controlled uncomplicated hypertension (systolic \>140 mm Hg and/or \>90 mm Hg after at least 5 minutes of seated rest), which is treated with no more than two drugs (either an ACE, ARB, calcium channel blocker, or diuretic)
- Cerebrovascular disease including previous stroke or aneurysm
- History of exercise-induced asthma
- History of type 1 diabetes mellitus or a history of ketoacidosis
- History of other specific types of diabetes (e.g., genetic syndromes, secondary pancreatic diabetes, diabetes due to endocrinopathies, drug or chemical-induced, and post organ transplant)
- History of respiratory disease including pulmonary hypertension or chronic obstructive pulmonary disease
- History of musculoskeletal or neurological disorders
- Active inflammatory bowel disease
- History of renal disease
- Other metabolic diseases, including hyper/ hypo-parathyroidism, hyper/hypo-thyroidism, and Cushing's disease.
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Stirlinglead
- Swansea Universitycollaborator
Study Sites (1)
Stirling Council
Stirling, FK49LA, United Kingdom
Related Publications (1)
Metcalfe RS, Atef H, Mackintosh K, McNarry M, Ryde G, Hill DM, Vollaard NBJ. Time-efficient and computer-guided sprint interval exercise training for improving health in the workplace: a randomised mixed-methods feasibility study in office-based employees. BMC Public Health. 2020 Mar 12;20(1):313. doi: 10.1186/s12889-020-8444-z.
PMID: 32164631DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 26, 2019
First Posted
May 7, 2019
Study Start
May 1, 2019
Primary Completion
September 13, 2019
Study Completion
November 13, 2019
Last Updated
March 24, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
data will be disseminated / published as means +- SD. no individual data will be presented.